About Cyrano Therapeutics
Cyrano Therapeutics is a Healthcare company based in Washington (United States) founded in 2014. It operates as a pharmaceutical therapies for smell and taste loss are developed. Cyrano Therapeutics has raised $25.88 million across 4 funding rounds from investors including Florida Opportunity Fund, Lumira Ventures and Remiges Ventures. Its focus areas include Alternative Medicine Products.
Company details
Cyrano Therapeutics was founded in 2014 as a biotechnology firm focused on olfactory disorders. Pharmaceutical treatments for long-term smell and taste loss, including hyposmia, are developed through research into underlying causes of dysfunction. Clinical trials are conducted to assess therapy safety and efficacy, with operations centered on restoring sensory function for affected patients.
- Headquarters Washington, United States
- SectorsHealthcare
- Email••••••••
- Website cyranotherapeutics.com
- Social LinkedIn
- Total Equity Funding$25.88M (USD)
in 4 rounds
- Latest Funding Round$9M (USD), Series B
Jan 2024
- InvestorsFlorida Opportunity Fund
& 3 more
Funding Insights of Cyrano Therapeutics
Cyrano Therapeutics has successfully raised a total of $25.88M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $9 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25.88M
- Total Rounds 4
- Last Round Series B — $9M
- Investors Count 4
All 4 funding rounds of Cyrano Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $9M | Series B | – | Florida Opportunity Fund, Lumira Ventures | – |
| Dec 2020 | $12.8M | Series A | – | Remiges Ventures, Lumira Ventures | – |
| Nov 2020 | $4.08M | Series A | – | – | – |
| Sep 2018 | – | Seed | – | – |
4 investors in total: 4 institutional.
Investors in Cyrano Therapeutics
Cyrano Therapeutics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Florida Opportunity Fund, Lumira Ventures and Remiges Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Fund-of-funds and VC investor funding companies in the US | – | floridaopportunityfund.com | Coral Gables, United States | |
Lumira Ventures is engaged in life sciences venture capital investment. | – | lumiraventures.com | Toronto, Canada | |
Remiges Ventures is engaged in biotech venture capital investments. | – | remigesventures.com | Seattle, United States | |
DORAHOKI is recognized as a pioneer in online lottery betting. | – | inovapha.org | - |
Investor details for Cyrano Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cyrano Therapeutics
7 people are tracked at Cyrano Therapeutics (4 in leadership, 3 in board & advisors).
| Name | Role | Group |
|---|---|---|
Rick Geoffrion | Founder, President & CEO | Leadership |
Krista Geoffrion | Vice President Clinical Operations | Leadership |
R. I. Henkin | Co-Founder & Chief Scientific Advisor | Leadership |
Ron Kuppersmith | Chief Medical Advisor | Leadership |
Taka Koda | Director | Board & advisors |
John Kollins | Director | Board & advisors |
Gerry Brunk | Director | Board & advisors |
Complete people profiles for Cyrano Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cyrano Therapeutics
3 dated milestones of Cyrano Therapeutics across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Cyrano Therapeutics is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $9.0M.
Top companies in Alternative Medicine Products
10 companies that operate in the same segment as Cyrano Therapeutics (Alternative Medicine Products), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Homeopathic medicine manufacturing and online retail in India. | 1898 | Noida, Uttar Pradesh, India | – | USD 26.35 M | 1,192 | |
Operates an online store specializing in ayurvedic and homeopathic medicines. | 2016 | Delhi, Delhi, India | – | USD 1.25 M | 16 | |
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness. | 1992 | Faridabad, Haryana, India | – | USD 10.08 M | 570 | |
Ayurvedic company manufacturing natural soaps, body washes, and health products. | 1969 | Chennai, Tamil Nadu, India | – | USD 51.17 M | 418 | |
Chinese medicines are researched, developed, manufactured, and supplied. | 2001 | Heze, Shandong, China | – | USD 1.68 B | – | |
Herbal medicines and supplements for health categories are manufactured. | 1933 | Neumarkt-sankt Veit, Bavaria, Germany | – | USD 510.09 M | 196 | |
Provides Ayurvedic healing therapies, massages, and wellness services in India. | – | Kochi, Kerala, India | – | USD 230.35 K | 42 | |
Homeopathic medicines are supplied and distributed by Boiron worldwide. | 1932 | Newtown Square, Pennsylvania, United States | – | – | – | |
Ayurvedic personal and sexual wellness products are manufactured and distributed. | 2015 | Mumbai, Maharashtra, India | – | USD 15.13 M | 38 | |
Natural healthcare products are manufactured by Lumiera Health Innovation. | 2020 | Halifax, Nova Scotia, Canada | – | – | 49 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cyrano Therapeutics
Complete news archive for Cyrano Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cyrano Therapeutics
Cyrano Therapeutics was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Cyrano Therapeutics is headquartered in Washington, United States. It is registered at Washington, District Of Columbia, United States.
Cyrano Therapeutics is a funded company, having raised a total of $25.88M across 4 funding rounds to date.
Cyrano Therapeutics was founded in 2014 as a biotechnology firm focused on olfactory disorders. Pharmaceutical treatments for long-term smell and taste loss, including hyposmia, are developed through research into underlying causes of dysfunction. Clinical trials are conducted to assess therapy safety and efficacy, with operations centered on restoring sensory function for affected patients.
Cyrano Therapeutics has 4 investors. Key investors include Florida Opportunity Fund, Lumira Ventures, Remiges Ventures, and DORAHOKI.